MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of […]
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters’ proven execution model Doubles Waters’ total addressable market to approximately $40 billion, with 5-7% annual growth Creates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion Increases […]
IDT launches all-inclusive gene fragments from 7 cents per base with 25% lower turnaround times and next-day shipping powered by its cutting-edge synthetic biology facility Global genomics solutions leader Integrated DNA Technologies (IDT), with an established reputation in scientific leadership and high-quality solutions for customers, has announced a brand-new center focused on custom genes. Driven […]
New high-throughput format expands the SimpleCell product line, empowering researchers to run larger, more complex studies with unprecedented ease and efficiency. SAN DIEGO — CS Genetics, a privately held genomics technology company, today announced the commercial launch of its 96-sample SimpleCell 3′ Gene Expression Kit, further expanding the capabilities of its SimpleCell platform for scalable, cost-efficient […]
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) today announced a planned CEO transition, marking a new chapter in the company’s successful growth story. After nearly 12 years with Tecan, including 6 ½ years as CEO, Dr. Achim von […]
Genomenon’s Curation and Distribution of Variant Data to Global Clinical Communities Reduces Barriers to Genetic Diagnosis Ann Arbor, MI – Genomenon, a leader in genomic intelligence, today announced a strategic partnership with UCB to accelerate awareness, diagnosis, and research for thymidine kinase 2 deficiency (TK2d). Through this collaboration, Genomenon has used its unique combination of AI and team […]
Integration of firefly® liquid handling platform and SemaCyte® microcarriers enables flexible, miniaturized, and automated cell assay workflows Cambridge, UK: SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug […]
Strategic collaboration enables scalable automation for ClaretBio’s advanced NGS library preparation kits on Hamilton’s industry-leading liquid handling platforms Claret Bioscience, a pioneer in next-generation sequencing (NGS) library preparation technologies for challenging samples, and Hamilton Company, a global leader in precision laboratory automation, are proud to announce a strategic co-promotion initiative. This collaboration aims to accelerate […]
BILLERICA, Mass. — Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology and immunology markets. Under the terms of […]
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies SEATTLE, Wash. — The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
